- ICTO 2017; Clinical Trials in Oncology & Hemato-Oncology, LondonMarch 16, 2017 - March 17, 2017
- BIO-Europe spring, BarcelonaMarch 20, 2017 - March 22, 2017
- Annual ReportMarch 22, 2017
Alligator Bioscience has a broad project portfolio with several antibody-based pharmaceuticals in immuno-oncology. Several of these R&D projects are operated in-house. The company's most advanced project, ADC-1013, is in clinical Phase I and is being developed together with partner Janssen Biotech.